Skip to main content

PEGASYSTEMS INC

For the period ended Dec 31, 2023. Filed Feb 14, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 14, 2024

PEGA$31.53+1.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Page
Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34)37
Consolidated Balance Sheets as of December 31, 2023 and 202239
Consolidated Statements of Operations for the years ended December 31, 2023, 2022, and 202140
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2023, 2022, and 202141
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2023, 2022, and 202142
Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022, and 202143
Notes to Consolidated Financial Statements44

To the stockholders and the Board of Directors of Pegasystems Inc.

Cambridge, Massachusetts

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Pegasystems Inc. and subsidiaries (the "Company") as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). We also have audited the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

Basis for Opinions

The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s report on and changes in internal control over financial reporting. Our responsibility is to express an opinion on these financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Revenue Recognition - Software License Arrangements — Refer to Note 2 to the financial statements

Critical Audit Matter Description

The Company generates revenue from multiple sources, including software license revenue primarily derived from license sales of the Company’s Pega Platform and other software applications, maintenance revenue from client support, and services revenue primarily derived from cloud sales of the Company’s hosted Pega Platform and other software applications and consulting services.

The Company’s license and cloud contracts with clients (“arrangements”) often contain multiple performance obligations. These performance obligations may be included in the same contract or negotiated separately. Additionally, the Company enters into amendments to previously executed contracts which constitute contract modifications. Certain complex arrangements require that management performs a detailed analysis of the contractual terms and the application of more complex accounting guidance. Factors with potentially significant judgements include:

Identification of the complete client arrangement

Accounting treatment of contract modifications

Valuation and allocation of identified material rights

Allocation of arrangement consideration to bundled fixed price work orders

Given the accounting complexity and the management judgment necessary to properly identify, classify, and account for performance obligations, auditing such estimates involved a high degree of auditor judgment when performing audit procedures and evaluating the license and cloud revenue arrangements.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to license and cloud revenue arrangements included the following, among others:

We tested the effectiveness of controls over revenue recognition, including those over the identification of performance obligations included in the transaction, accounting treatment of contract modifications, valuation and allocation of identified material rights, and allocation of arrangement consideration.

We selected a sample of client arrangements, and performed the following:

Evaluated whether the Company properly identified the terms of the arrangements and considered all arrangement terms that may have an impact on revenue recognition.

Evaluated whether the Company appropriately identified all performance obligations in the arrangement and whether the methodology to allocate the transaction price to the individual performance obligations was appropriately applied.

Tested the accuracy of management’s calculation of revenue for each performance obligation by developing an expectation for the revenue to be recorded in the current period and comparing it to the Company’s recorded balances.

Evaluated management’s assessment of any ongoing negotiations with clients and bundling with statements of work.

Analyzed the proper accounting treatment for any contract modifications based on 1) whether the additional products and services are distinct from the products and services in the original arrangement, and 2) whether the amount of consideration expected for the added products and services reflects the stand-alone selling price of those products and services.

Evaluated management’s determination of whether certain renewal clauses, additional product offers, or additional usage offers represent material rights included in the contract and whether they were properly valued based on the incremental discount provided and the probability of the right being exercised.

For contracts with a performance obligation of bundled fixed price services, evaluated whether management reasonably estimated the number of hours that each project will require and independently recalculated the stand-alone selling price for each bundled fixed price service.

Obtained evidence of delivery of the elements of the arrangement to the client.

/s/Deloitte & Touche LLP

Boston, Massachusetts

February 14, 2024

We have served as the Company's auditor since 2000.

December 31, 2023December 31, 2022
Assets
Current assets:
Cash and cash equivalents$229,902$145,054
Marketable securities193,436152,167
Total cash, cash equivalents, and marketable securities423,338297,221
Accounts receivable, net300,173255,150
Unbilled receivables, net237,379213,719
Other current assets68,13780,388
Total current assets1,029,027846,478
Long-term unbilled receivables, net85,40295,806
Goodwill81,61181,399
Other long-term assets314,696333,989
Total assets$1,510,736$1,357,672
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$11,290$18,195
Accrued expenses39,94150,355
Accrued compensation and related expenses126,640127,728
Deferred revenue377,845325,212
Other current liabilities21,34317,450
Total current liabilities577,059538,940
Long-term convertible senior notes, net499,368593,609
Long-term operating lease liabilities66,90179,152
Other long-term liabilities13,57015,128
Total liabilities1,156,8981,226,829
Commitments and contingencies (Note 20)
Stockholders’ equity:
Preferred stock, $0.01 par value, 1,000 shares authorized; none issued——
Common stock, $0.01 par value, 200,000 shares authorized; 83,840 and 82,436 shares issued and outstanding as of December 31, 2023 and 2022, respectively838824
Additional paid-in capital379,584229,602
(Accumulated deficit)(8,705)(76,513)
Accumulated other comprehensive (loss)
Net unrealized gain on available-for-sale securities, net of tax669517
Foreign currency translation adjustments(18,548)(23,587)
Total stockholders’ equity353,838130,843
Total liabilities and stockholders’ equity$1,510,736$1,357,672
Year Ended December 31,
202320222021
Revenue
Subscription services$793,184$701,835$621,223
Subscription license407,625366,063336,248
Consulting221,706230,654222,010
Perpetual license10,10119,29332,172
Total revenue1,432,6161,317,8451,211,653
Cost of revenue
Subscription services144,250138,736120,446
Subscription license2,6062,6422,389
Consulting231,560227,082213,299
Perpetual license67175229
Total cost of revenue378,483368,635336,363
Gross profit1,054,133949,210875,290
Operating expenses
Selling and marketing559,177624,789625,886
Research and development295,512294,349260,630
General and administrative96,743117,73483,506
Restructuring21,74721,743—
Total operating expenses973,1791,058,615970,022
Income (loss) from operations80,954(109,405)(94,732)
Foreign currency transaction (loss) gain(5,242)4,560(6,459)
Interest income9,2591,643704
Interest expense(6,876)(7,792)(7,956)
(Loss) on capped call transactions(1,348)(57,382)(23,633)
Other income, net18,6936,57989
Income (loss) before provision for (benefit from) income taxes95,440(161,797)(131,987)
Provision for (benefit from) income taxes27,632183,785(68,947)
Net income (loss)$67,808$(345,582)$(63,040)
Earnings (loss) per share
Basic$0.82$(4.22)$(0.77)
Diluted$0.73$(4.22)$(0.77)
Weighted-average number of common shares outstanding
Basic83,16281,94781,387
Diluted84,91481,94781,387

(in thousands)

Year Ended December 31,
202320222021
Net income (loss)$67,808$(345,582)$(63,040)
Other comprehensive income (loss), net of tax
Unrealized gain (loss) on available-for-sale securities152(169)640
Foreign currency translation adjustments5,039(15,913)(4,680)
Total other comprehensive income (loss), net of tax5,191(16,082)(4,040)
Comprehensive income (loss)$72,999$(361,664)$(67,080)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Common Stock · Additional paid-in capital · Retained earnings (accumulated deficit) · Accumulated other comprehensive (loss) · Total stockholders’ equity
Number of shares · Amount
January 1, 202180,890$809$204,432$339,879$(2,948)$542,172
Cumulative-effect adjustment from adoption of ASU 2020-06, net——(61,604)9,399—(52,205)
Repurchase of common stock(432)(5)(53,605)——(53,610)
Issuance of common stock for stock compensation plans1,15312(69,937)——(69,925)
Issuance of common stock under the employee stock purchase plan101110,553——10,554
Stock-based compensation——115,971——115,971
Cash dividends declared ($0.12 per share)———(9,789)—(9,789)
Other comprehensive (loss)————(4,040)(4,040)
Net (loss)———(63,040)—(63,040)
December 31, 202181,712$817$145,810$276,449$(6,988)$416,088
Repurchase of common stock(280)(2)(24,506)——(24,508)
Issuance of common stock for stock compensation plans7547(20,627)——(20,620)
Issuance of common stock under the employee stock purchase plan25029,170——9,172
Stock-based compensation——122,229——122,229
Cash dividends declared ($0.12 per share)——(2,474)(7,380)—(9,854)
Other comprehensive (loss)————(16,082)(16,082)
Net (loss)———(345,582)—(345,582)
December 31, 202282,436$824$229,602$(76,513)$(23,070)$130,843
Issuance of common stock for stock compensation plans1,212128,893——8,905
Issuance of common stock under the employee stock purchase plan19227,742——7,744
Stock-based compensation——143,352——143,352
Cash dividends declared ($0.12 per share)——(10,005)——(10,005)
Other comprehensive income————5,1915,191
Net income———67,808—67,808
December 31, 202383,840$838$379,584$(8,705)$(17,879)$353,838

(in thousands)

Year Ended December 31,
202320222021
Operating activities
Net income (loss)$67,808$(345,582)$(63,040)
Adjustments to reconcile net income (loss) to cash provided by operating activities
Stock-based compensation143,352122,210115,947
Amortization of deferred commissions59,46153,47141,387
Amortization of intangible assets and depreciation18,74618,78028,593
Lease expense15,91215,94013,277
Foreign currency transaction (loss) gain5,242(4,560)6,459
Loss on capped call transactions1,34857,38223,633
Deferred income taxes363168,890(75,336)
(Gain) on investments(10,841)(6,578)(89)
(Gain) on repurchases of convertible senior notes(7,855)——
Other non-cash2,2556,7357,819
Change in operating assets and liabilities:
Accounts receivable, unbilled receivables, and contract assets(57,602)(51,157)(11,957)
Other current assets11,360(9,133)17,209
Other current liabilities(8,777)529(18,726)
Deferred revenue45,12362,57841,279
Deferred commissions(44,529)(53,857)(71,451)
Other long-term assets and liabilities(23,581)(13,312)(15,886)
Cash provided by operating activities217,78522,33639,118
Investing activities
Purchases of investments(287,287)(41,015)(79,121)
Proceeds from maturities and called investments242,59366,583105,977
Sales of investments10,72523,80861,096
Payments for acquisitions, net of cash acquired—(922)(4,993)
Investment in property and equipment(16,781)(35,379)(10,456)
Cash (used in) provided by investing activities(50,750)13,07572,503
Financing activities
Repurchases of convertible senior notes(88,989)——
Dividend payments to stockholders(9,964)(9,834)(9,761)
Proceeds from employee stock purchase plan7,7449,17210,554
Proceeds from stock option exercises10,821——
Common stock repurchases for tax withholdings for net settlement of equity awards(1,916)(20,620)(69,925)
Common stock repurchases under stock repurchase program—(25,707)(52,711)
Other341——
Cash (used in) financing activities(81,963)(46,989)(121,843)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash2,701(3,333)(1,712)
Net increase (decrease) in cash, cash equivalents and restricted cash87,773(14,911)(11,934)
Cash, cash equivalents, and restricted cash, beginning of period145,054159,965171,899
Cash, cash equivalents, and restricted cash, end of period$232,827$145,054$159,965
Supplemental disclosures
Interest paid on convertible notes$4,134$4,500$4,500
Income taxes paid (refunded)$11,664$7,645$(4,552)
Non-cash investing and financing activity:
Investment in property and equipment included in accounts payable and accrued liabilities$66$9,914$2,143
Dividends payable$2,515$2,474$2,454

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

  1. BASIS OF PRESENTATION

The Company develops, markets, licenses, hosts, and supports enterprise software that helps organizations build agility into their business. The Company’s low-code platform for workflow automation and artificial intelligence-powered decisioning enables clients to personalize customer experiences, streamline customer service, and automate business processes and workflows. The Company provides consulting, training, support, and hosting services to facilitate the use of its software.

Management estimates and reporting

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S.”) requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Accounts with reported amounts based on significant estimates and judgments include, but are not limited to, revenue, unbilled receivables, deferred revenue, deferred income taxes, deferred commissions, income taxes payable, convertible senior notes, capped call transactions, intangible assets, and goodwill.

Principles of consolidation

The Company’s consolidated financial statements reflect Pegasystems Inc. and subsidiaries in which the Company holds a controlling financial interest. All intercompany accounts and transactions were eliminated in consolidation.

Reclassifications

Certain prior period amounts reported in our consolidated financial statements and notes thereto have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, income (loss) from operations, or net income (loss).

  1. SIGNIFICANT ACCOUNTING POLICIES

Revenue

The Company’s revenue is primarily derived from:

Subscription services, composed of revenue from Pega Cloud and maintenance. Pega Cloud is the Company’s hosted Pega Platform and software applications. Maintenance revenue is earned from providing client support, software upgrades, and bug fixes or patches.

Subscription license, composed of revenue from term license arrangements for the Company’s Pega Platform and software applications. Term licenses represent functional intellectual property and are delivered separately from maintenance and services.

Perpetual license, composed of revenue from perpetual license arrangements for the Company’s Pega Platform and software applications. Perpetual licenses represent functional intellectual property and are delivered separately from maintenance and services.

Consulting, primarily related to new software license implementations, training, and reimbursable costs.

Performance obligations

The Company’s software license and Pega Cloud arrangements often contain multiple performance obligations. If a contract contains multiple performance obligations, the Company accounts for each distinct performance obligation separately. The transaction price is allocated to the separate performance obligations on a relative stand-alone selling price basis. Any discounts or expected potential future price concessions are considered when determining the total transaction price. The Company’s policy is to exclude sales and similar taxes collected from clients from the determination of transaction price.

The Company’s typical performance obligations are:

Performance obligationHow stand-alone selling price is typically determinedWhen performance obligation is typically satisfiedWhen payment is typically dueIncome statement line item
Perpetual licenseResidual approachUpon transfer of control to the client, defined as when the client can use and benefit from the license (point in time)Effective date of the licensePerpetual license
Term licenseResidual approachUpon transfer of control to the client, defined as when the client can use and benefit from the license (point in time)Annually, or more frequently, over the term of the licenseSubscription license
MaintenanceConsistent pricing relationship as a percentage of the related license and observable in stand-alone renewal transactions (1)Ratably over the term of the maintenance (over time)Annually, or more frequently, over the term of the maintenanceSubscription services
Pega CloudResidual approachRatably over the term of the service (over time)Annually, or more frequently, over the term of the serviceSubscription services
Consulting- time and materialsObservable hourly rate for time and materials-based services in similar geographiesBased on hours incurred to date (over time)MonthlyConsulting
Consulting - fixed priceObservable hourly rate for time and materials-based services in similar geographies multiplied by estimated hours for the projectBased on hours incurred as a percentage of total estimated hours (over time)As contract milestones are achievedConsulting

(1) Technical support and software updates are considered distinct services but accounted for as a single performance obligation, as they have the same pattern of transfer to the client.

The Company utilizes the residual approach for software license and Pega Cloud performance obligations since the selling price is highly variable and the stand-alone selling price is not discernible from past transactions or other observable evidence. Periodically, the Company reevaluates whether the residual approach remains appropriate. As required, the Company evaluates its residual approach estimate compared to all available observable data before concluding the estimate represents its stand-alone selling price.

If the contract grants the client the option to acquire additional products or services, the Company assesses whether the option represents a material right to the client that the client would not receive without entering into that contract. Discounts on options to purchase additional products and services greater than discounts available to similar clients are accounted for as an additional performance obligation.

During most of each client contract term, the amount invoiced is generally less than the amount of revenue recognized to date, primarily because we transfer control of the performance obligation related to the software license at the inception of the contract term. A significant portion of the total contract consideration is typically allocated to the license performance obligation. Therefore, the Company’s contracts often result in the recording of unbilled receivables and contract assets throughout most of the contract term. The Company records an unbilled receivable or contract asset when revenue recognized on a contract exceeds the billings. The Company recognizes an impairment on receivables and contract assets if, after contract inception, it becomes probable that payment is not collectible. The Company reviews receivables and contract assets on an individual basis for impairment.

Variable consideration

The Company’s arrangements can include variable fees, such as the option to purchase additional usage of a previously delivered software license. The Company may also provide pricing concessions to clients, a business practice that gives rise to variable fees. For variable fees arising from the client’s acquisition of additional usage of a previously delivered software license, the Company applies the sales and usage-based royalties guidance related to a license of intellectual property and recognizes the revenue in the period the underlying sale or usage occurs. The Company includes variable fees in the determination of total transaction price if it is not probable that a significant future reversal of revenue will occur. The Company uses the expected value or most likely value amount, whichever is more appropriate for specific circumstances, to estimate variable consideration, and the estimates are based on the level of historical price concessions offered to clients. The variable consideration related to pricing concessions and other forms of variable consideration, including usage-based fees, have not been material to the Company’s consolidated financial statements.

Significant financing components

The Company generally does not intend to provide financing to its clients, as financing arrangements are not contemplated as part of the negotiated terms of contracts between the Company and its clients. Although there may be an intervening period between the delivery of the license and the payment, typically in term license arrangements, the purpose of that timing difference is to align the client’s payment with the timing of the use of the software license or service.

In certain circumstances, however, there are instances where revenue recognition timing differs from the timing of payment due to extended payment terms or fees that are non-proportional to the associated usage of software licenses. In these instances, the Company evaluates whether a significant financing component exists. This evaluation includes determining the difference between the consideration the client would have paid when the performance obligation was satisfied and the amount of consideration paid. Contracts that include a significant financing component are adjusted for the time value of money at the rate inherent in the contract, the client’s borrowing rate, or the Company’s incremental borrowing rate, depending upon the recipient of the financing.

During 2023, 2022, and 2021, significant financing components were not material.

Contract modifications

The Company assesses contract modifications to determine:

if the additional products and services are distinct from the products and services in the original arrangement; and

if the amount of consideration expected for the added products and services reflects the stand-alone selling price of those products and services.

A contract modification meeting both criteria is accounted for as a separate contract. If a contract modification does not meet both criteria, it is accounted for either:

on a prospective basis as a termination of the existing contract and the creation of a new contract; or

on a cumulative catch-up basis.

Deferred commissions

The Company recognizes an asset for the incremental costs of obtaining a client contract, primarily related to sales commissions. The Company expects to benefit from those costs for more than one year, as the Company primarily pays sales commissions on the initial contract. As a result, there are no commensurate commissions paid on contract renewals. Deferred commissions are allocated to each performance obligation within the contract and amortized according to the transfer of underlying goods and services within those contracts and expected renewals. The expected benefit period is determined based on the length of the client contracts, client attrition rates, the underlying technology lifecycle, and the competitive marketplace’s influence on the products and services sold. Deferred costs allocated to maintenance and deferred costs for Pega Cloud arrangements are amortized over an average expected benefit period of 4.5 years. Deferred costs allocated to software licenses, and any expected renewals of term software licenses within the 4.5 years expected benefit period, are amortized at the point in time control of the software license is transferred. Deferred costs allocated to consulting are amortized over a period consistent with the pattern of transfer of control for the related services.

Financial instruments

The principal financial instruments held by the Company consist of cash equivalents, marketable securities, receivables, capped call transactions, and accounts payable. The Company considers debt securities readily convertible to known amounts of cash with maturities of three months or less from the purchase date to be cash equivalents. Interest is recorded when earned. The Company’s investments are classified as available-for-sale and are carried at fair value. Unrealized gains and losses considered temporary are recorded as a component of accumulated other comprehensive (loss), net of related income taxes. The Company reviews all investments for reductions in fair value that are other-than-temporary. When such reductions occur, the investment cost is adjusted to fair value by recording a loss on investments in the consolidated statements of operations. Gains and losses on investments are calculated based on the specific investment.

For additional information see "Note 4. Receivables, Contract Assets, And Deferred Revenue", "Note 11. Debt", and "Note 13. Fair Value Measurements".

Property and equipment

Property and equipment are recorded at cost. Depreciation and amortization are computed using the straight-line method over the estimated useful life of each asset, which arethree years for computer equipment andfive years for furniture and fixtures. Leasehold improvements are amortized over the lesser of the lease’s term or the useful life of the asset. Repairs and maintenance costs are expensed as incurred.

Leases

All of the Company’s leases are operating leases, primarily composed of office space leases. The Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset’s economic benefits. The Company determines the initial classification and measurement of its operating right of use assets and lease liabilities at the lease commencement date and thereafter if modified. Fixed lease costs are recognized on a straight-line basis over the lease term. Variable lease costs are recognized in the period in which the obligation for those payments is incurred. The Company combines lease and non-lease components when determining lease costs for its office space leases. The lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain it will exercise those options. The Company’s leases do not contain material residual value guarantees or restrictive covenants.

Loss contingencies and legal costs

The Company accrues loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.

Significant judgments are required to determine the probability and the range of the outcomes, and the estimates are based only on the information available to the Company at the time. Due to the inherent uncertainties involved in claims, legal proceedings, and in estimating the losses that may arise, actual outcomes may differ from the Company’s estimates. Contingencies deemed not probable, or for which losses were not estimable in one period, may become probable or losses may become estimable in later periods, which may have a material impact on the Company’s results of operations and financial position. As additional information becomes available, the Company reassesses the potential liability from pending claims and litigation and may revise its estimates. Regardless of the outcome, legal disputes can have a material effect on the Company because of defense and settlement costs, diversion of management resources and other factors. Legal costs are expensed as incurred.

Internal-use software

The Company capitalizes and amortizes certain direct costs associated with computer software developed or purchased for internal use incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. The Company amortizes capitalized software costs generally over three tofive years, commencing on the date the software is placed into service.

Goodwill

Goodwill represents the residual purchase price paid in a business combination after the fair value of all identified assets and liabilities have been recorded. Goodwill is not amortized. The Company has a single reporting unit. The Company performed a qualitative assessments as of November 30, 2023, 2022, and 2021, respectively, and concluded that there was no impairment since it was not more-likely-than-not that the fair value of its reporting unit was less than its carrying value.

Intangible and long-lived assets

The Company’s intangible assets are amortized using the straight-line method over their estimated useful life. The Company evaluates its long-lived tangible and intangible assets for impairment whenever events or changes in circumstances indicate that such assets’ carrying amount may not be recoverable. Impairment is assessed by comparing the undiscounted cash flows expected to be generated by the long-lived tangible or intangible assets to their carrying value. If impairment exists, the Company calculates the impairment by comparing the carrying value to its fair value as determined by discounted expected cash flows.

Cash equivalents

Cash equivalents include money market funds and other investments with original maturities of three months or less.

Business combinations

The Company uses its estimates and assumptions to assign a fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. The Company’s estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related valuation allowances are initially established in connection with a business combination as of the acquisition date. The Company reevaluates these estimates and assumptions quarterly as new information arises and records any adjustments to the Company’s preliminary estimates to goodwill provided that the Company is within the measurement period. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations.

Research and development and software development costs

Research and development costs are expensed as incurred. Capitalization of computer software developed for resale begins upon the establishment of technological feasibility, generally demonstrated by a working model or an operative version of the computer software product. Such costs have not been material to date, as technological feasibility is established within a short time frame from the software’s general availability. As a result, no costs were capitalized in 2023, 2022, or 2021.

Stock-based compensation

The Company recognizes stock-based compensation expense associated with equity awards based on the award’s fair value at the grant date. Stock-based compensation is recognized over the requisite service period, which is generally the vesting period of the equity award and is adjusted each period for anticipated forfeitures. See "Note 16. Stock-Based Compensation" for a discussion of the Company’s key assumptions when determining the fair value of its equity awards at the grant date.

Foreign currency translation and remeasurement

The translation of assets and liabilities for the Company’s subsidiaries with functional currencies other than the U.S. dollar are made at period-end exchange rates. Revenue and expense accounts are translated at the average exchange rates during the period transactions occur. The resulting translation adjustments are reflected in accumulated other comprehensive (loss). Realized and unrealized exchange gains or losses from transactions and remeasurement adjustments are reflected in foreign currency transaction gain (loss) in the accompanying consolidated statements of operations.

Accounting for income taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on temporary differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The Company regularly assesses the need for a valuation allowance against its deferred tax assets. Future realization of the Company’s deferred tax assets ultimately depends on sufficient taxable income within the available carryback or carryforward periods. Taxable income sources include taxable income in prior carryback years, future reversals of existing taxable temporary differences, tax planning strategies, and projected future taxable income. The Company records a valuation allowance to reduce its deferred tax assets to an amount it believes is more-likely-than-not to be realized. Changes in the valuation allowance impact income tax expense in the period of adjustment. The Company recognizes excess tax benefits when realized, as a reduction of the provision for income taxes.

The Company assesses its income tax positions and records tax benefits based on management’s evaluation of the facts, circumstances, and information available at the reporting date. For those tax positions where it is more-likely-than-not that a tax benefit will be sustained, the Company records the largest amount of tax benefit with a greater than 50 percent likelihood of being realized upon ultimate settlement with a taxing authority having full knowledge of all relevant information. For those income tax positions where it is not more-likely-than-not that a tax benefit will be sustained, no tax benefit is recognized in the financial statements. The Company classifies liabilities for uncertain tax positions as non-current liabilities unless the uncertainty is expected to be resolved within one year. The Company classifies interest and penalties on uncertain tax positions as income tax expense.

As a global company, significant judgment must be used to calculate and provide for income taxes in each of the tax jurisdictions in which it operates. In the ordinary course of the Company’s business, there are transactions and calculations undertaken whose ultimate tax outcome cannot be certain. Some of these uncertainties arise because of transfer pricing for transactions with the Company’s subsidiaries and nexus and tax credit estimates. In addition, the calculation of acquired tax attributes and the associated limitations are complex.

For additional information, see "Note 18. Income Taxes".

Advertising expense

Advertising costs are expensed as incurred. Advertising expenses were $3.5 million, $6.6 million, and $11.8 million during 2023, 2022, and 2021, respectively.

  1. MARKETABLE SECURITIES
December 31, 2023December 31, 2022
(in thousands)Amortized CostUnrealized GainsUnrealized LossesFair ValueAmortized CostUnrealized GainsUnrealized LossesFair Value
Government debt$11,471$33$(1)$11,503$2,960$—$(52)$2,908
Corporate debt181,960200(227)181,933151,906—(2,647)149,259
$193,431$233$(228)$193,436$154,866$—$(2,699)$152,167

As of December 31, 2023, marketable securities’ maturities ranged from January 2024 to January 2026, with a weighted-average remaining maturity of 0.7 years.

  1. RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE

Receivables

(in thousands)December 31, 2023December 31, 2022
Accounts receivable, net$300,173$255,150
Unbilled receivables, net237,379213,719
Long-term unbilled receivables, net85,40295,806
$622,954$564,675

Unbilled receivables

Unbilled receivables are client-committed amounts for which revenue recognition precedes billing. Billing is solely subject to the passage of time.

Unbilled receivables by expected collection date:

(Dollars in thousands)December 31, 2023
1 year or less$237,37974%
1-2 years62,58519%
2-5 years22,8177%
$322,781100%

Unbilled receivables by contract effective date:

(Dollars in thousands) · December 31, 2023
2023$208,78365%
202256,21617%
202146,47314%
20208,6833%
2019 and prior2,6261%
$322,781100%

Contract assets

Contract assets are client-committed amounts for which revenue recognized exceeds the amount billed to the client, and billing is subject to conditions other than the passage of time, such as the completion of a related performance obligation.

(in thousands)December 31, 2023December 31, 2022
Contract assets (1)$16,238$17,546
Long-term contract assets (2)20,63516,470
$36,873$34,016

(1) Included in other current assets.

(2) Included in other long-term assets.

Deferred revenue

Deferred revenue consists of billings and payments received in advance of revenue recognition.

(in thousands)December 31, 2023December 31, 2022
Deferred revenue$377,845$325,212
Long-term deferred revenue (1)2,4783,552
$380,323$328,764

(1) Included in other long-term liabilities.

The change in deferred revenue in 2023 was primarily due to new billings in advance of revenue recognition and $319.5 million of revenue recognized during the period included in deferred revenue as of December 31, 2022.

  1. DEFERRED COMMISSIONS
December 31,
(in thousands)20232022
Deferred commissions (1)$114,119$130,195
(in thousands)202320222021
Amortization of deferred commissions (1)$59,461$53,471$41,387

(1) Included in selling and marketing expenses.

  1. PROPERTY AND EQUIPMENT(1)
(in thousands)December 31,
20232022
Leasehold improvements$62,787$35,049
Computer equipment31,14427,292
Furniture and fixtures6,6655,993
Computer software purchased10,0609,724
Computer software developed for internal use19,47019,869
Fixed assets in progress22337,342
130,349135,269
Less: accumulated depreciation(83,070)(80,213)
$47,279$55,056
(in thousands)202320222021
Depreciation expense$14,806$14,687$24,606
  1. GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

(in thousands)20232022
January 1,$81,399$81,923
Currency translation adjustments212(524)
December 31,$81,611$81,399

Intangibles

Intangible assets are recorded at cost and amortized using the straight-line method over their estimated useful lives:

(in thousands)Useful LivesCostAccumulated AmortizationNet Book Value (1)
Client-related4-10 years$63,117$(60,035)$3,082
Technology2-10 years68,138(64,218)3,920
Other1-5 years5,361(5,361)—
$136,616$(129,614)$7,002
(in thousands)Useful LivesCostAccumulated AmortizationNet Book Value (1)
Client-related4-10 years$63,076$(58,623)$4,453
Technology2-10 years68,056(61,621)6,435
Other1-5 years5,361(5,361)—
$136,493$(125,605)$10,888

(1)Included in other long-term assets.

Future estimated intangible assets amortization:

(in thousands)December 31, 2023
2024$3,182
20252,619
2026874
2027327
$7,002

Amortization of intangible assets:

(in thousands)202320222021
Cost of revenue$2,570$2,723$2,516
Selling and marketing1,3701,3701,471
$3,940$4,093$3,987
  1. OTHER ASSETS AND LIABILITIES

Other current assets

(in thousands)December 31, 2023December 31, 2022
Income tax receivables$4,804$25,354
Contract assets16,23817,546
Other47,09537,488
$68,137$80,388

Other long-term assets

(in thousands)December 31, 2023December 31, 2022
Deferred commissions$114,119$130,195
Right of use assets64,19876,114
Property and equipment47,27955,056
Venture investments19,45013,069
Contract assets20,63516,470
Intangible assets7,00210,888
Capped call transactions8932,582
Deferred income taxes3,6784,795
Restricted cash2,925—
Other34,51724,820
$314,696$333,989

Other current liabilities

(in thousands)December 31, 2023December 31, 2022
Operating lease liabilities$15,000$14,976
Dividends payable2,5152,474
Other$3,828$—
$21,343$17,450

Other long-term liabilities

(in thousands)December 31, 2023December 31, 2022
Deferred revenue$2,478$3,552
Income taxes payable8593,207
Other10,2338,369
$13,570$15,128
  1. SEGMENT INFORMATION

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance.

The Company derives substantially all of its revenue from the sale and support of one group of similar products and services – software that provides case management, business process management, and real-time decisioning solutions to improve customer engagement and operational excellence in the enterprise applications market. To assess performance, the Company’s CODM, the Chief Executive Officer, reviews financial information on a consolidated basis. Therefore, the Company determined it hasone operating segment andone reporting unit.

Long-lived assets related to the Company’s U.S. and international operations were:

(Dollars in thousands) · December 31, 2023 · December 31, 2022
U.S.$44,41494%$50,44592%
International2,8656%4,6118%
$47,279100%$55,056100%
  1. LEASES

Corporate headquarters

In February 2021, the Company agreed to accelerate its exit from its previous corporate headquarters to October 1, 2021, in exchange for a one-time payment from its landlord of $18 million, which was amortized over the remaining lease term. The exit accelerated depreciation on the related leasehold improvements and reduced the Company’s future lease liabilities by $21.1 million and right of use assets by $20.3 million. On March 31, 2021, the Company leased office space at One Main Street, Cambridge, Massachusetts, to serve as its corporate headquarters. The 4.5 year lease includes a base rent of $2 million per year.

Waltham office

On July 6, 2021, the Company entered into an office space lease for 131 thousand square feet in Waltham, Massachusetts. The lease term of 11 years began on August 1, 2021. The annual rent equals the base rent plus a portion of building operating costs and real estate taxes. Rent first became payable on August 1, 2022. Base rent for the first year is approximately $6 million and will increase by 3% annually. In addition, the Company received an improvement allowance from the landlord of $11.8 million. This lease increased the Company’s lease liabilities and lease-related right of use assets by $42.1 million on August 1, 2021.

Expense

(in thousands)202320222021
Fixed lease costs (1)$19,718$20,186$(1,694)
Short-term lease costs2,8843,3562,244
Variable lease costs8,1483,8944,480
$30,750$27,436$5,030

(1) The lower fixed lease costs in 2021 was due to the modification of the corporate headquarters lease.

Right of use assets and lease liabilities

(in thousands)December 31, 2023December 31, 2022
Right of use assets (1)$64,198$76,114
Operating lease liabilities (2)$15,000$14,976
Long-term operating lease liabilities$66,901$79,152

(1) Represents the Company’s right to use the leased asset during the lease term. Included in other long-term assets.

(2) Included in other current liabilities.

The weighted-average remaining lease term and discount rate for the Company’s leases were:

December 31, 2023December 31, 2022
Weighted-average remaining lease term6.8 years7.5 years
Weighted-average discount rate (1)4.0%4.1%

(1) The rates implicit in most of the Company’s leases are not readily determinable. Therefore, the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur to borrow an amount equal to the lease payments on a collateralized basis over the lease term in a similar economic environment.

Maturities of lease liabilities:

(in thousands)December 31, 2023
2024$17,971
202515,602
202611,164
202710,114
20289,372
Thereafter30,177
Total lease payments94,400
Less: imputed interest (1)(12,499)
$81,901

(1) Lease liabilities are measured at the present value of the remaining lease payments using a discount rate determined at lease commencement unless the discount rate is updated due to a lease reassessment event.

Cash flow information (1)

(in thousands)20232022
Cash paid for operating leases, net of tenant improvement allowances$20,045$7,690
Right of use assets recognized for new leases and amendments (non-cash)$1,460$4,733

(1) In 2022, the Company received a tenant improvement allowances of $8.8 million as part of the lease of the Company’s new corporate headquarters in Waltham, Massachusetts.

  1. DEBT

Convertible senior notes and capped calls

Convertible senior notes

In February 2020, the Company issued convertible senior notes (the "Notes") with an aggregate principal of $600 million, due March 1, 2025, in a private placement. No principal payments are due before maturity. The Notes accrue interest at an annual rate of 0.75%, payable semi-annually in arrears on March 1 and September 1, beginning September 1, 2020.

In 2023, the Company recognized a gain of $7.9 million in other income, net from repurchases of Notes representing $97.7 million in aggregate principal amount.

Conversion rights

The conversion rate is 7.4045 shares of common stock per $1,000 principal amount of the Notes, representing an initial conversion price of $135.05 per share of common stock. The conversion rate will be adjusted upon certain events, including spin-offs, tender offers, exchange offers, and certain stockholder distributions. The Company will settle conversions by paying or delivering cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate.

Beginning on September 1, 2024, noteholders may convert their Notes at any time at their election.

Before September 1, 2024, noteholders may convert their Notes in the following circumstances:

During any calendar quarter beginning after June 30, 2020 (and only during such calendar quarter), if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter.

During thefive consecutive business days immediately after anyfive consecutive trading day period (the “Measurement Period”), if the trading price per $1,000 principal amount of Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price per share of common stock on such trading day and the conversion rate on such trading day.

Upon certain corporate events or distributions or if the Company calls any Notes for redemption, noteholders may convert before the close of business on the business day immediately before the related redemption date (or, if the Company fails to pay the redemption price in full on the redemption date until the Company pays the redemption price).

As of December 31, 2023, the Notes were not eligible for conversion.

Repurchase rights

On or after March 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, the Company may redeem for cash all or part of the Notes at a repurchase price equal to 100% of the principal amount, plus accrued and unpaid interest, if the last reported sale price of the Company’s common stock exceeded 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides a redemption notice.

If certain corporate events that constitute a “Fundamental Change” occur, each noteholder will have the right to require the Company to repurchase for cash all of such noteholder’s Notes, or any portion of the principal thereof that is equal to $1,000 or a multiple of $1,000, at a repurchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. A Fundamental Change relates to mergers, changes in control of the Company, liquidation/dissolution of the Company, or the delisting of the Company’s common stock.

Carrying value of the Notes:

(in thousands)December 31, 2023December 31, 2022
Principal$502,270$600,000
Unamortized issuance costs(2,902)(6,391)
Convertible senior notes, net$499,368$593,609

Interest expense related to the Notes:

(in thousands)20232022
Contractual interest expense (0.75% coupon)$3,891$4,500
Amortization of issuance costs2,6032,888
$6,494$7,388

The average interest rate on the Notes in 2023 and 2022 was 1.2%.

Future payments of principal and contractual interest:

December 31, 2023
(in thousands)PrincipalInterestTotal
2024$—$3,767$3,767
2025502,2701,884504,154
$502,270$5,651$507,921

Capped call transactions

In February 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”) with certain financial institutions. The Capped Call Transactions initially covered approximately 4.4 million shares (representing the number of shares for which the Notes were initially convertible) of the Company’s common stock. In 2023, Capped Call Transactions covering approximately 0.7 million shares were settled for proceeds of $0.3 million. As of December 31, 2023, Capped Call Transactions covering approximately 3.7 million shares were outstanding.

The Capped Call Transactions are expected to reduce common stock dilution and/or offset any potential cash payments the Company must make, other than for principal and interest, upon conversion of the Notes, with such reduction and/or offset subject to a cap of $196.44. The cap price of the Capped Call Transactions is subject to adjustment upon specified extraordinary events affecting the Company, including mergers and tender offers.

The capped call transactions are accounted for as derivative instruments and do not qualify for the Company’s own equity scope exception in ASC 815 since, in some cases of early settlement, the settlement value calculated following the governing documents may not represent a fair value measurement. The Capped Call Transactions are classified as other long-term assets and remeasured to fair value each reporting period, resulting in a non-operating gain or loss.

Change in capped call transactions:

(in thousands)20232022
January 1,$2,582$59,964
Settlements(341)—
Fair value adjustment(1,348)(57,382)
December 31,$893$2,582

Credit facility

In November 2019, and as since amended, the Company entered into afive-year $100 million senior secured revolving credit agreement (the “Credit Facility”) with PNC Bank, National Association. The Company may use borrowings for general corporate purposes and to finance working capital needs. Subject to specific conditions and the agreement of the financial institutions lending the additional amount, the aggregate commitment may be increased to $200 million. The commitments expire on November 4, 2024, and any outstanding loans will be payable on such date. The Credit Facility, as amended, contains customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions.

The Company is required to comply with financial covenants, including:

Through December 31, 2023, Pegasystems Inc. must maintain at least $200 million in cash, investments, and availability under the Credit Facility and the Company must maintain:

Year to Date
(in thousands)March 31, 2023June 30, 2023September 30, 2023December 31, 2023
Minimum Consolidated EBITDA (as defined in the Credit Facility)$38,862$59,894$95,597$214,590

Beginning with the fiscal quarter ended March 31, 2024, a maximum net consolidated leverage ratio of 3.5 to 1.0 (with a step-up for certain acquisitions) and a minimum consolidated interest coverage ratio of 3.5 to 1.0.

As of December 31, 2023 and December 31, 2022, the Company had $27.3 million in outstanding letters of credit, reducing available borrowing capacity under the Credit Facility, butno outstanding cash borrowings.

  1. RESTRUCTURING

The Company has undertaken the following restructuring activities as it optimizes its go-to-market strategy and reassesses its office space needs:

(in thousands)Three months endedExpense
Employee severance and related benefits and office space reductionDecember 31, 2022$21,743
Office space reductionMarch 31, 2023$1,241
Employee severance and related benefitsJune 30, 2023$1,581
Employee severance and related benefits and office space reductionSeptember 30, 2023$17,236
Office space reductionDecember 31, 2023$1,497

Restructuring activity:

Accrued employee severance and related benefits:

(in thousands)2023
January 1,$18,573
Costs incurred18,721
Cash disbursements(29,401)
Currency translation adjustments202
December 31,$8,095

Note: Included in accrued compensation and related expenses.

Office Space reductions

In 2023 and 2022, the Company incurred restructuring costs of $3.0 million and $3.2 million due to office space reductions.

  1. FAIR VALUE MEASUREMENTS

Assets and liabilities measured at fair value on a recurring basis

The Company records its cash equivalents, marketable securities, capped call transactions, and venture investments at fair value on a recurring basis. Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability.

As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows:

Level 1 - observable inputs, such as quoted prices in active markets for identical assets or liabilities;

Level 2 - significant other inputs that are observable either directly or indirectly; and

Level 3 - significant unobservable inputs with little or no market data, which require the Company to develop its own assumptions.

This hierarchy requires the Company to use observable market data when available and minimize unobservable inputs when determining fair value.

The fair value of the Capped Call Transactions at the end of each reporting period is determined using a Black-Scholes option-pricing model. The valuation model uses various market-based inputs, including stock price, remaining contractual term, expected volatility, risk-free interest rate, and expected dividend yield. The Company applies judgment when determining expected volatility. The Company considers the underlying equity security’s historical and implied volatility levels. The Company’s venture investments are recorded at fair value based on multiple valuation methods, including observable public companies and transaction prices and unobservable inputs, including the volatility, rights, and obligations of the securities the Company holds.

Assets and liabilities measured at fair value on a recurring basis:

December 31, 2023December 31, 2022
(in thousands)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Cash equivalents$54,357$—$—$54,357$2,526$—$—$2,526
Marketable securities$—$193,436$—$193,436$—$152,167$—$152,167
Capped Call Transactions (1)$—$893$—$893$—$2,582$—$2,582
Venture investments (1) (2)$—$—$19,450$19,450$—$—$13,069$13,069

(2) Investments in privately-held companies.

Changes in venture investments:

Year EndedDecember 31,
(in thousands)20232022
January 1,$13,069$7,648
New investments4001,400
Sales of investments(2,773)(4,020)
Changes in foreign exchange rates129(450)
Changes in fair value:
included in other income, net10,8865,989
included in other comprehensive income (loss)(2,261)2,502
December 31,$19,450$13,069

The carrying value of certain financial instruments, including receivables and accounts payable, approximates fair value due to their short maturities.

Fair value of the Notes

The fair value of the Notes outstanding (including the embedded conversion feature) was $466.5 million as of December 31, 2023 and $521.1 million as of December 31, 2022. In the year ended December 31, 2023 the Company repurchased Notes representing $97.7 million in aggregate principal amount.

The fair value was determined based on the Notes’ quoted price in an over-the-counter market on the last trading day of the reporting period and classified within Level 2 in the fair value hierarchy.

Credit risk

In addition to receivables, the Company is potentially subject to concentrations of credit risk from the Company’s cash, cash equivalents, and marketable securities. The Company’s cash and cash equivalents are generally held with large, diverse financial institutions worldwide to reduce the Company’s credit risk exposure. Investment policies have been implemented that limit purchases of marketable debt securities to investment-grade securities.

  1. STOCKHOLDERS’ EQUITY

Preferred stock

The Company has 1 million authorized shares of preferred stock, $0.01 par value per share, of which none were issued and outstanding as of December 31, 2023.

The Board of Directors has the authority to issue the shares of preferred stock in one or more series, to establish the number of shares to be included in each series, and to determine the designation, powers, preferences, and rights of the shares of each series and the qualifications, limitations, or restrictions thereof, without any further vote or action by the stockholders. The issuance of preferred stock could decrease the earnings and assets available for distribution to holders of common stock and may have the effect of delaying, deferring, or defeating a change in control of the Company.

Common stock

The Company has 200 million authorized shares of common stock, $0.01 par value per share, of which 83.8 million were issued and outstanding as of December 31, 2023.

Dividends declared

202320222021
Dividends declared (per share)$0.12$0.12$0.12
Dividend payments to stockholders (in thousands)$9,964$9,834$9,761

The Company paid a quarterly cash dividend of $0.03 per share in 2023, 2022, and 2021. In the future, the Board of Directors may terminate or modify the dividend program without prior notice.

Stock repurchases

(in thousands) · 2023 · 2022 · 2021
Shares · Amount · Shares · Amount · Shares · Amount
January 1,$58,075$22,583$37,726
Authorizations (1)1,92560,00038,467
Repurchases (2)——(280)(24,508)(432)(53,610)
December 31,$60,000$58,075$22,583

(1) On April 25, 2023, the Company announced that the Board of Directors extended the current stock repurchase program’s expiration date to June 30, 2024 and increased the remaining stock repurchase authority to $60 million.

(2) Purchases under this program have been made on the open market.

  1. REVENUE

Geographic revenue

(Dollars in thousands) · 2023 · 2022 · 2021
U.S.$785,02955%$763,55857%$690,13357%
Other Americas85,1496%102,9808%61,3395%
United Kingdom (“U.K.”)158,01411%115,7939%117,58010%
Europe (excluding U.K.), Middle East, and Africa242,30317%194,56315%198,08016%
Asia-Pacific162,12111%140,95111%144,52112%
$1,432,616100%$1,317,845100%$1,211,653100%

Revenue streams

(in thousands)202320222021
Subscription license$407,625$366,063$336,248
Perpetual license10,10119,29332,172
Revenue recognized at a point in time417,726385,356368,420
Pega Cloud461,328384,271300,966
Maintenance331,856317,564320,257
Consulting221,706230,654222,010
Revenue recognized over time1,014,890932,489843,233
$1,432,616$1,317,845$1,211,653
(in thousands)202320222021
Pega Cloud$461,328$384,271$300,966
Maintenance331,856317,564320,257
Subscription services793,184701,835621,223
Subscription license407,625366,063336,248
Subscription1,200,8091,067,898957,471
Consulting221,706230,654222,010
Perpetual license10,10119,29332,172
$1,432,616$1,317,845$1,211,653

Remaining performance obligations ("Backlog")

Expected future revenue from existing non-cancellable contracts:

As of December 31, 2023:

(Dollars in thousands) · Subscription services · Subscription license · Perpetual license · Consulting · Total
MaintenancePega Cloud
1 year or less$245,271$446,160$62,070$2,284$39,810$795,59554%
1-2 years67,720279,4749,1384432,020358,79525%
2-3 years37,142144,4539,789—2,896194,28013%
Greater than 3 years24,42190,177100——114,6988%
$374,554$960,264$81,097$2,727$44,726$1,463,368100%

As of December 31, 2022:

(Dollars in thousands) · Subscription services · Subscription license · Perpetual license · Consulting · Total
MaintenancePega Cloud
1 year or less$242,073$379,648$60,668$5,310$32,374$720,07353%
1-2 years66,207246,1953,8032,2536,371324,82924%
2-3 years26,746143,9011,707—1,647174,00113%
Greater than 3 years15,602115,9445,283——136,82910%
$350,628$885,688$71,461$7,563$40,392$1,355,732100%
  1. STOCK-BASED COMPENSATION
(in thousands)202320222021
Cost of revenue$28,994$26,400$21,822
Selling and marketing57,67546,76954,182
Research and development31,03929,26625,413
General and administrative25,64419,77514,530
$143,352$122,210$115,947
Income tax benefit$(2,187)$(1,881)$(23,410)

The Company periodically grants employees stock options and restricted stock units (“RSUs”) and non-employee Directors common stock and stock options.

In 2021 and 2022, most of the Company’s stock based compensation arrangements vest over five years, with 20% vesting afterone year and the remaining 80% vesting quarterly over the remaining four years. Beginning in 2023, most of the Company’s stock based compensation arrangements vest over four years, with 25% vesting after one year and the remaining 75% vesting quarterly over the remaining three years. The Company’s stock options have a term often years. In 2023, the Company also granted 0.9 million performance stock options with a total grant date fair value of $18.3 million, which vest over 2 years based on the Company’s achievement of certain financial performance targets.

The Company recognizes stock-based compensation using the accelerated attribution method, treating each vesting tranche as an individual grant. The stock-based compensation expense recognized during a period is based on the value of the awards that are expected to vest. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the Company recognizes the actual expense over the vesting period only for the shares that vest.

Employees may elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash. If elected by an employee, the equity amount is equal in value on the grant date to 50% of the employee’s target incentive opportunity, based on the employee’s base salary. The number of RSUs granted is determined by dividing 50% of the employee’s target incentive opportunity by 85% of the closing price of the Company’s common stock on the grant date, less the present value of expected dividends during the vesting period. If elected, the award vests 100% on the following year’s CICP payout date. Vesting is conditioned upon the performance conditions of the CICP and on continued employment; if threshold funding does not occur, the RSUs will not vest. The Company considers vesting probable on the grant date and recognizes the associated stock-based compensation expense over the requisite service period beginning on the grant date and ending on the vesting date.

Historically, the Company has granted awards that allow for the settlement of vested stock options and RSUs on a net share basis (“net settled awards”). With net settled awards, the Company withholds shares to cover the exercise price (for stock options) and the minimum statutory tax withholding obligations (for stock options and RSUs) from the shares that would otherwise be issued upon exercise or settlement. In 2023, the Company moved to cashless settlement for most of its awards. Under cashless settlement, shares are automatically sold in the market at exercise (for stock options) or vest (for RSUs) to cover the exercise price (for stock options) and the minimum statutory tax withholding obligations (for stock options and RSUs).

Stock-based compensation plans

2004 Long-Term Incentive Plan (as amended and restated)

In 2004, the Company adopted the 2004 Long-Term Incentive Plan (as amended and restated, the “2004 Plan”) to provide employees, non-employee Directors, and consultants with opportunities to purchase stock through incentive and non-qualified stock options. Subsequent amendments to the plan increased the number of shares authorized for issuance under the plan to 42 million, extended the term of the plan to 2030, and limited annual compensation to any non-employee Director to $0.5 million.

As of December 31, 2023,17.4 million shares were subject to outstanding options and stock-based awards under the 2004 Plan.

2006 Employee Stock Purchase Plan

In 2006, the Company adopted the 2006 Employee Stock Purchase Plan (the “2006 ESPP”) under which employees may purchase common stock, at a price equal to at least 85% of the fair market value of the Company’s common stock on the lesser of the commencement date or completion date for offerings under the plan, or such higher price as the Company’s Board of Directors may establish from time to time. In October 2012, the Company’s Board of Directors amended the 2006 ESPP to continue until no shares remain. In 2023, the number of shares authorized for purchase under the 2006 ESPP was increased to 2 million. For 2023, 2022, and 2021, the Company’s Board of Directors set the purchase price at 85% of the fair market value on the completion date of the offering period.

(in thousands)202320222021
Compensation expense from 2006 ESPP$1,367$1,614$1,860

As of December 31, 2023,1.0 million shares had been issued under the plan.

Shares issued and available for issuance

In 2023, the Company issued 1.4 million shares to its employees and directors under the Company’s stock-based compensation plans.

As of December 31, 2023, there were 6.9 million shares available for issuance for future equity grants under the Company’s stock plans, consisting of 5.9 million shares under the 2004 Plan and 1.0 million shares under the 2006 ESPP.

Grant activity

Stock options

The Company estimates the fair value of stock options using a Black-Scholes option-pricing model. Key inputs used to estimate the fair value of stock options include the exercise price of the award, expected term of the option, expected volatility of the Company’s common stock over the option’s expected term, risk-free interest rate over the option’s expected term, and the Company’s expected annual dividend yield. The exercise price for stock options is greater than or equal to the shares’ fair market value at the grant date.

The following table summarizes the Company’s fair value assumptions for stock options:

202320222021
Weighted-average grant-date fair value$20.55$17.49$37.74
Assumptions used in the Black-Scholes option-pricing model:
Expected annual volatility (1)48%42%35%
Expected term in years (2)3.53.94.4
Risk-free interest rate (3)4.2%3.4%0.6%
Expected annual dividend yield (4)0.1%0.1%0.2%

(1) The expected annual volatility for each grant is determined based on the average of historic daily price changes of the Company’s common stock over a period, which approximates the expected option term.

(2) The expected option term for each grant is determined based on the historical exercise behavior of employees and post-vesting employment termination behavior.

(3) The risk-free interest rate is based on the yield of U.S. Treasury securities with a commensurate maturity with the expected option term at the time of grant.

(4) The expected annual dividend yield is based on the weighted-average dividend yield assumptions used for options granted during the applicable period.

The following table summarizes the combined stock option activity under the Company’s stock option plans for 2023:

Shares (in thousands)Weighted-average Exercise PriceWeighted-average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands) (1)
Options outstanding as of January 1, 202314,911$59.67
Granted1,84746.97
Exercised(380)31.56
Forfeited(1,289)55.90
Expired(350)81.62
Options outstanding as of December 31, 202314,739$58.60
Vested and expected to vest as of December 31, 202312,786$58.587.3$73,407
Exercisable as of December 31, 20236,761$63.546.1$32,594

(1) The aggregate intrinsic value of stock options as of December 31, 2023 is based on the difference between the closing price of the Company’s stock of $48.86 and the exercise price of the applicable stock options.

The aggregate intrinsic value of stock options exercised (i.e., the difference between the market price at exercise and the price paid by the employee at exercise) in 2023, 2022, and 2021 was $6.2 million, $15.6 million, and $94.3 million, respectively. As of December 31, 2023, the Company had unrecognized stock-based compensation expense related to the unvested portion of stock options of $57.8 million that is expected to be recognized as expense over a weighted-average period of 1.6 years.

RSUs

RSUs provide the recipient a right to receive a specified number of shares of the Company’s common stock upon vesting. The Company values its RSUs at the fair value of its common stock on the grant date, which is the closing price of its common stock on the grant date less the present value of expected dividends during the vesting period, as the recipient is not entitled to dividends during the requisite service period.

The weighted-average grant-date fair value for RSUs granted in 2023, 2022, and 2021 was $46.57, $74.50, and $129.03, respectively.

The following table summarizes the combined RSU activity for all grants, including the CICP, under the 2004 Plan for 2023:

Shares (in thousands)Weighted- Average Grant-Date Fair ValueAggregate Intrinsic Value (in thousands)
Nonvested as of January 1, 20232,351$85.52
Granted1,54546.57
Vested(890)84.74
Forfeited(390)71.56
Nonvested as of December 31, 20232,616$64.85$127,805
Expected to vest as of December 31, 20231,968$62.86$96,168

The fair value of RSUs vested in 2023, 2022, and 2021 was $42.8 million, $50.3 million, and $122.5 million, respectively. The aggregate intrinsic value of RSUs outstanding and expected to vest as of December 31, 2023 is based on the closing price of the Company’s stock of $48.86 as of December 31, 2023.

As of December 31, 2023, the Company had $48.6 million of unrecognized stock-based compensation expense related to all unvested RSUs that is expected to be recognized as expense over a weighted-average period of 1.7 years.

Common stock

In 2023, the Company granted 0.01 million shares of common stock to Directors with a weighted-average grant-date fair value of $47.25 per share.

  1. EMPLOYEE BENEFIT PLANS

The Company sponsors defined contribution plans for qualifying employees, including a 401(k) plan in the United States to which the Company makes discretionary matching contributions.

Employee benefit plan expenses:

(in thousands)202320222021
U.S. 401(k) Plan$8,169$8,994$8,879
International plans21,25621,14120,780
$29,425$30,135$29,659
  1. INCOME TAXES

The components of income (loss) before provision for (benefit from) income taxes are:

(in thousands)202320222021
Domestic$14,016$(185,820)$(125,947)
Foreign81,42424,023(6,040)
$95,440$(161,797)$(131,987)

The components of provision for (benefit from) income taxes are:

(in thousands)202320222021
Current:
Federal$7,827$3,920$1,921
State4,480775363
Foreign14,96210,2004,105
Total current provision27,26914,8956,389
Deferred:
Federal—149,028(42,214)
State—20,704(9,413)
Foreign363(842)(23,709)
Total deferred provision (benefit)363168,890(75,336)
$27,632$183,785$(68,947)

A reconciliation of the U.S federal statutory tax rate and the Company’s effective tax rate:

(in thousands)202320222021
U.S. federal income taxes at statutory rates$20,042$(33,977)$(27,717)
Valuation allowance(19,272)188,258(469)
State income taxes, net of federal benefit and tax credits4,117(2,433)(7,217)
Permanent differences43511,561541
Federal research and experimentation credits(3,709)(5,012)(6,380)
Tax effects of foreign activities6583,7703,599
GILTI, FDII, and BEAT14,02216,390—
Provision to return adjustments(3,728)(6,317)(2,016)
Non-deductible compensation6,8184,7695,464
Tax Reserves1,8505,673(2,250)
Excess tax detriments / (benefits) related to share-based compensation4,6661,563(20,697)
Impact of change in tax law1,726(793)(11,811)
Other73336
$27,632$183,785$(68,947)

Deferred income taxes

Significant components of net deferred tax assets and liabilities are:

December 31,
(in thousands)20232022
Deferred tax assets:
Net operating loss carryforwards$84,656$109,286
Accruals and reserves41,32332,467
Interest expense carryforward—208
Software revenue3,1861,828
Convertible senior notes2,6455,794
Depreciation—3,698
Tax credit carryforwards28,45639,122
Research and development capitalization58,86638,425
Other—622
Total deferred tax assets219,132231,450
Valuation allowances(196,901)(212,808)
Total net deferred tax assets22,23118,642
Deferred tax liabilities:
Capped call transactions(223)(644)
Depreciation(4,428)—
Intangibles(11,979)(14,280)
Other, net(2,782)—
Total deferred tax liabilities(19,412)(14,924)
$2,819$3,718

The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. Future realization of deferred tax assets ultimately depends on sufficient taxable income within the available carryback or carryforward periods. The Company’s deferred tax valuation allowance requires significant judgment and has uncertainties, including assumptions about future taxable income based on historical and projected information. On a quarterly basis, the Company reassesses the need for a valuation allowance on its existing net deferred tax assets by tax-paying jurisdiction, weighing positive and negative evidence to assess its recoverability. In making such a determination, the Company considers all available and objectively verifiable negative and positive evidence, including future reversals of existing taxable temporary differences, projected future taxable income inclusive of the impact of enacted legislation, tax-planning strategies, and results of recent operations. The weight given to the potential effect of negative and positive evidence is commensurate with the extent to which it can be objectively verified.

The Company determined that the objectively and verifiable negative evidence outweighed the positive evidence and as such intends to maintain a full valuation allowance on its U.S and U.K deferred tax assets until there is sufficient evidence to support the realization of these deferred tax assets. Accordingly, the Company recorded a valuation allowance of $196.9 million at December 31, 2023.

As of December 31, 2023, the Company’s U.S. net operating losses and credit carryforwards are:

(in thousands)FederalState
Net operating losses (1)$20,624$8,766
Net operating losses due to acquisitions (1)$20,624$2,195
Credit carryforwards (2)$26,464$3,435
Credit carryforwards due to acquisitions$640$60

(1) Excludes federal and state net operating losses of $16.1 million and $0.8 million, respectively, from prior acquisitions that the Company expects will expire unutilized.

(2) Excludes federal and state tax credits of $0.1 million and $10.7 million, respectively, that the Company expects will expire unutilized.

The Company’s federal carryforward losses and credits expire between 2024 and 2041, except for $1.4 million of state credits, which has an unlimited carryforward period. The Company’s U.K. net operating loss carryforwards were $183.1 million and $217.3 million at December 31, 2023 and 2022, respectively, which have indefinite carryforward periods.

Uncertain tax benefits

A rollforward of the Company’s gross unrecognized tax benefits is:

(in thousands)202320222021
Balance as of January 1,$19,746$17,584$23,801
Additions for tax positions related to the current year4,8591,706653
Additions for tax positions of prior years7,921728—
Reductions for tax positions of prior years(1,871)(272)(6,870)
Balance as of December 31,$30,655$19,746$17,584

Due to the valuation allowance on the U.S. and U.K. deferred tax assets, the Company does not expect the unrecognized tax benefits to materially impact the Company’s effective tax rate if recognized.

Tax examinations

The Company files federal and state income tax returns in the U.S. and various foreign jurisdictions. In the ordinary course of business, the Company and its subsidiaries are examined by various tax authorities, including the Internal Revenue Service in the U.S. As of December 31, 2023, the Company’s U.S. federal tax returns for the years 2014 through 2019 were under examination by the Internal Revenue Service. In addition, certain foreign jurisdictions are auditing the Company’s income tax returns for periods ranging from 2013 through 2021. The Company does not expect the results of these audits to have a material effect on the Company’s financial condition, results of operations, or cash flows. With few exceptions, the statute of limitations remains open in all jurisdictions for all tax years since 2017.

  1. EARNINGS (LOSS) PER SHARE

Basic earnings (loss) per share is calculated using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is calculated using the weighted-average number of common shares outstanding during the period, plus the dilutive effect of outstanding stock options, RSUs, and convertible senior notes.

Calculation of earnings (loss) per share:

(in thousands, except per share amounts)202320222021
Net income (loss)$67,808$(345,582)$(63,040)
Weighted-average common shares outstanding83,16281,94781,387
Earnings (loss) per share, basic$0.82$(4.22)$(0.77)
Net income (loss)$67,808$(345,582)$(63,040)
Convertible senior notes - interest expense and settlement gains, net of tax(5,528)——
Numerator for diluted EPS$62,280$(345,582)$(63,040)
Weighted-average effect of dilutive securities:
Convertible senior notes235——
Stock options794——
RSUs723——
Effect of dilutive securities1,752——
Weighted-average common shares outstanding, assuming dilution (1) (2) (3)84,91481,94781,387
Earnings (loss) per share, diluted$0.73$(4.22)$(0.77)
Outstanding anti-dilutive stock options and RSUs (4)2503,3675,862

(1) All dilutive securities are excluded in periods of loss as their inclusion would be anti-dilutive.

(2) The shares underlying the conversion options in the Company’s Notes are included using the if-converted method, if dilutive in the period. If the outstanding conversion options were fully exercised, the Company would issue approximately 3.7 million shares as of December 31, 2023.

(3) The Company’s Capped Call Transactions represent the equivalent of approximately 3.7 million shares of the Company’s common stock (representing the number of shares for which the Notes are convertible) as of December 31, 2023. The Capped Call Transactions are expected to reduce common stock dilution and/or offset any potential cash payments the Company must make, other than for principal and interest, upon conversion of the Notes, with such reduction and/or offset subject to a cap of $196.44. The Capped Call Transactions are excluded from weighted-average common shares outstanding, assuming dilution, in all periods as their effect would be anti-dilutive.

(4) Outstanding stock options and RSUs that were anti-dilutive under the treasury stock method in the period were excluded from the computation of diluted earnings (loss) per share. These awards may be dilutive in the future.

  1. COMMITMENTS AND CONTINGENCIES

Commitments

For additional information, see "Note 10. Leases".

In addition to the matters below, the Company is or may become involved in a variety of claims, demands, suits, investigations, and proceedings that arise from time to time relating to matters incidental to the ordinary course of the Company’s business, including actions concerning contracts, intellectual property, employment, benefits, and securities matters. Regardless of the outcome, legal disputes can have a material effect on the Company because of defense and settlement costs, diversion of management resources, and other factors.

In addition, as the Company is a party to ongoing litigation, it is at least reasonably possible that the Company’s estimates will change in the near term, and the effect may be material.

The Company hadno accrued losses for litigation as of December 31, 2023 and December 31, 2022.

Appian Corp. v. Pegasystems Inc. & Youyong Zou

As previously reported, the Company is a defendant in litigation brought by Appian in the Circuit Court of Fairfax County, Virginia (the “Court”) titled Appian Corp. v. Pegasystems Inc. & Youyong Zou, No. 2020-07216 (Fairfax Cty. Ct.). On May 9, 2022, the jury rendered its verdict finding that the Company had misappropriated one or more of Appian’s trade secrets, that the Company had violated the Virginia Computer Crimes Act, and that the trade secret misappropriation was willful and malicious. The jury awarded damages of $2,036,860,045 for trade secret misappropriation and $1.00 for violating the Virginia Computer Crimes Act. On September 15, 2022, the circuit court of Fairfax County entered judgment of $2,060,479,287, consisting of the damages previously awarded by the jury plus attorneys’ fees and costs, and stating that the judgment is subject to post-judgment interest at a rate of 6.0% per annum, from the date of the jury verdict (May 9, 2022) as to the amount of the jury verdict and from September 15, 2022 as to the amount of the award of attorneys’ fees and costs. On September 15, 2022, the Company filed a notice of appeal from the judgment. On September 29, 2022, the circuit court of Fairfax County approved a $25,000,000 letter of credit obtained by the Company to secure the judgment and entered an order suspending the judgment during the pendency of the Company’s appeal. Appellate briefing in the Court of Appeals of Virginia is completed. A panel of the Court of Appeals of Virginia heard oral arguments on November 15, 2023, and will issue a written opinion in the future. Although it is not possible to predict timing, the entirety of the appeals process could potentially take years to complete. The Company continues to believe that it did not misappropriate any alleged trade secrets and that its sales of the Company’s products at issue were not caused by, or the result of, any alleged misappropriation of trade secrets. The Company is unable to reasonably estimate possible damages because of, among other things, uncertainty as to the outcome of appellate proceedings and/or any potential new trial resulting from the appellate proceedings.

City of Fort Lauderdale Police and Firefighters’ Retirement System, Individually and on Behalf of All Others Similarly Situated v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell

On May 19, 2022, a lawsuit was filed against the Company, the Company’s chief executive officer and the Company’s chief operating and financial officer in the United States District Court for the Eastern District of Virginia Alexandria Division, captioned City of Fort Lauderdale Police and Firefighters’ Retirement System, Individually and on Behalf of All Others Similarly Situated v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell (Case 1:22-cv-00578-LMB-IDD). The complaint generally alleges, among other things, that the defendants violated Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Rule 10b-5 promulgated thereunder and that the individual defendants violated Section 20(a) of the Exchange Act, in each case by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The complaint seeks unspecified damages on behalf of a class of purchasers of the Company’s securities between May 29, 2020 and May 9, 2022. The litigation has since been transferred to the United States District Court for the District of Massachusetts (Case 1:22-cv-11220-WGY), and lead plaintiff class representatives—Central Pennsylvania Teamsters Pension Fund - Defined Benefit Plan, Central Pennsylvania Teamsters Pension Fund - Retirement Income Plan 1987, and Construction Industry Laborers Pension Fund—have been appointed. On October 18, 2022, a consolidated amended complaint was filed that does not add any new parties or legal claims, is based upon the same general factual allegations as the original complaint, and now seeks unspecified damages on behalf of a class of purchasers of the Company’s securities between June 16, 2020 and May 9, 2022. The Company moved to dismiss the consolidated amended complaint on December 19, 2022. The hearing on the Company’s motion to dismiss took place on May 17, 2023. After hearing argument from both sides, the Court denied the Company’s motion from the bench and stated that a written opinion would follow. On June 30, 2023, the Company filed its Answer to the complaint. On July 24, 2023, the Court issued its written opinion denying the motion to dismiss as to the Company and Defendant Trefler but granting the motion without prejudice as to Mr. Stillwell. The Company believes it has strong defenses to the claims brought against the defendants and intends to defend against these claims vigorously. The Company is unable to reasonably estimate possible damages or a range of possible damages in this matter given the stage of the lawsuit, the Company’s belief that it has strong defenses to the claims asserted, its intent to defend against these claims, and there being no specified quantum of damages sought in the complaint.

In re Pegasystems Inc., Derivative Litigation

On November 21, 2022, a lawsuit was filed against the members of the Company’s board of directors, the Company’s chief operating and financial officer and the Company in the United States District Court for the District of Massachusetts, captioned Mary Larkin, derivatively on behalf of nominal defendant Pegasystems Inc. v. Peter Gyenes, Richard Jones, Christopher Lafond, Dianne Ledingham, Sharon Rowlands, Alan Trefler, Larry Weber, and Kenneth Stillwell, defendants, and Pegasystems Inc., nominal defendant (Case 1:22-cv-11985). The complaint generally alleges the defendants sold shares of the Company while in possession of material nonpublic information relating to (i) the litigation brought by Appian in the Circuit Court of Fairfax County, Virginia, described above, and (ii) alleged misconduct by Company employees alleged in that litigation. On April 28, 2023, a lawsuit was filed in the United States District Court for the District of Massachusetts by Dag Sagfors, derivatively on behalf of nominal defendant Pegasystems Inc., asserting breach of fiduciary duty and related claims relating to the Virginia Appian litigation against the same defendants as the Larkin lawsuit. On May 17, 2023, the Larkin and Sagfors cases were consolidated and a joint motion to stay the consolidated case is pending before the Court. The Company also has received confidential demand letters raising substantially the same allegations set forth in the foregoing derivative complaints. On April 12, 2023, the Company’s board of directors (other than Mr. Trefler, who recused himself), formed a committee consisting solely of independent directors, to review, analyze, and investigate the matters raised in the demands and to determine in good faith what actions (if any) are reasonably believed to be appropriate under similar circumstances and reasonably believed to be in the best interests of the Company in response to the demand letters. The Company is unable to reasonably estimate possible damages or a range of possible damages in this matter given the stage of the lawsuit and there being no specified quantum of damages sought in the complaint.

SEC Inquiry

Beginning in March 2023, the U.S. Securities and Exchange Commission (“SEC”) has requested certain information relating to, among other things, the accounting treatment of the Company’s above-described litigation with Appian Corporation. The Company is fully cooperating with the SEC’s requests.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.